A case of fatal Guillain-Barre syndrome from anti-PD1 monoclonal antibody use.
Monmouth Medical Center, Long Branch, NJ, USA. aajacob@barnabashealth.org.
Aasems
http://orcid.org/0000-0002-7783-3786
A
Jacob
Monmouth Medical Center, Long Branch, NJ, USA.
Dileep C
DC
Unnikrishnan
University of Kentucky Markey Cancer Center, Lexington, KY, USA.
Aju
A
Mathew
Monmouth Medical Center, Long Branch, NJ, USA.
Braghadheeswar
B
Thyagarajan
Monmouth Medical Center, Long Branch, NJ, USA.
Shil
S
Patel
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D020275:Guillain-Barre Syndrome / Q000209:etiology*; D006801:Humans; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*
D000911:Antibodies, Monoclonal; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab